Introduction
============

*Burkholderia pseudomallei* is a soil dwelling Gram-negative bacterium that causes the potentially fatal disease melioidosis in humans and animals. Infection with *B. pseudomallei* may affect virtually any organ and may encompass a wide array of non-specific clinical manifestations ranging from acute pneumonia and sepsis to localized abscess formation, making diagnosis difficult ([@B27]; [@B106]). The mortality rate can reach 40% despite appropriate antibiotic therapy. Southeast Asia and Northern Australia are hyperendemic regions ([@B23]). However, reports of environmental *B. pseudomallei* isolates or melioidosis cases from Central and South America, Africa and South Asia indicate that the bacteria are found in the tropics worldwide ([@B61]; [@B68]; [@B84]; [@B93]). Furthermore, a recent comprehensive modeling study suggests vast underreporting of melioidosis cases and highlights the need to assess the true global burden and epidemiology of the disease ([@B54]).

*Burkholderia thailandensis* is used as a surrogate model for the Tier I Select Agent *B. pseudomallei*. Reports of human infections with *B. thailandensis* are exceedingly rare and the LD~50~ of *B. thailandensis* in mammalian animal models is at least 100 fold higher than that of *B. pseudomallei* ([@B83]; [@B12]; [@B53]; [@B38]; [@B101]; [@B20]; [@B37]). Yet, at higher inocula via the respiratory tract, *B. thailandensis* causes rapidly fatal infections in mice and the manifestations such as neutrophil influx to the lungs, pulmonary inflammatory cytokine response, multifocal pneumonia and extra-pulmonary dissemination are similar to *B. pseudomallei* infections ([@B101], [@B102]; [@B104]). Furthermore, both bacteria are facultative intracellular parasites and important regulatory systems and virulence factors of *B. pseudomallei* such as quorum sensing, type III and type VI secretion systems are conserved in *B. thailandensis* ([@B40]; [@B59]; [@B92]). *B. pseudomallei* encodes six type VI secretion systems (T6SSs) and orthologs of five of them are present in *B. thailandensis* ([@B73]; [@B76]). The analysis, so far, of three of the *Burkholderia* T6SSs revealed a high functional diversity: while the T6SS-1 and T6SS-4 are involved in interbacterial competition and metal ion acquisition, respectively, the T6SS-5 plays a central role in the intracellular life cycle of the bacteria ([@B75]; [@B34]; [@B71]; [@B79]).

The Intracellular Life Cycle of *Burkholderia Pseudomallei* and *Burkholderia Thailandensis*
============================================================================================

Since *B. pseudomallei* is only sporadically transmitted between humans and *B. thailandensis* infections of humans are extremely rare, the capacity of the bacteria for survival and virulence in mammals likely has its origin in the exposure of the bacteria to soil dwelling predators such as protozoa ([@B1]; [@B67]; [@B32]). *B. pseudomallei* is able to survive phagocytosis by protozoa, which has been suggested as pre-adaptation to avoid killing by mammalian phagocytes ([@B35]; [@B45]; [@B88]). Indeed, *B. pseudomallei* and *B. thailandensis* are able to survive inside a range of mammalian phagocytic and non-phagocytic host cells ([@B46]; [@B81]; [@B6]; [@B56]; [@B103]).

A detailed discussion on the intracellular life cycle is beyond the scope of this review and we refer the reader to several comprehensive overviews on this topic ([@B2]; [@B87]; [@B107]). In brief, upon passive or active entry into the host cell the bacteria are located in a membrane-bound vacuole ([@B46]; Figure [1A](#F1){ref-type="fig"}). Before lysosomal fusion *B. pseudomallei* and *B. thailandensis* escape the endocytic vacuole, a process that is significantly impaired in T3SS-3 mutants ([@B86]; [@B97]). Once in the cytosol of the host cell the bacteria replicate and employ BimA to facilitate actin tail formation or the flagella fla2 system for intracellular motility ([@B85]; [@B34]; [@B82]). Intercellular spread of *B. pseudomallei* and *B. thailandensis* can occur directly without exposure of the bacteria to the extracellular milieu by the formation of multinucleated giant cells (MNGCs). MNGCs are the result of plasma membrane fusion and subsequent cytoplasmic mixing of the infected and neighboring host cell ([@B47]; [@B8]; [@B34]). These cell-cell fusions have been detected in lung tissue samples of melioidosis patients and mice infected with a low dose of *B. pseudomallei* ([@B109]; [@B26]). Essential to MNGC formation is the *Burkholderia* T6SS-5 (also named cluster 1 T6SS) whose mechanism of action is still unknown ([@B64]; [@B17]; [@B34]; [@B91]; [@B74]). Furthermore, findings on the T6SS-5 of *Burkholderia mallei*, which is closely related to *B. pseudomallei*, are discussed in the review ([@B73]; [@B55]).

![**(A)** Schematic representation of the intracellular life cycle of *Burkholderia pseudomallei* and *Burkholderia thailandensis*: (i) entry into phagocytic or non-phagocytic cell, (ii) vacuole formation, (iii) vacuolar escape before lysosomal fusion, (iv) replication and intracellular motility in cytoplasm, and (v) T6SS-5-dependent induction of plasma membrane fusion of neighboring host cell leading to MNGCs. **(B)** Genetic organization of the T6SS-5 gene cluster in *B. pseudomallei* (Bp) and *B. thailandensis* (Bt). *tss*, *tag* and regulatory genes are highlighted in dark, mid and light gray, respectively. **(C)** Schematic representation of the *B. pseudomallei* (Bp) VgrG-5, TagD-5 and Hcp-5 domain organization in comparison with Bp VgrG-6 (UniProt: Q63II0), RhsA (PAAR domain containing protein of *Dickeya dadantii;* UniProt: E0SAK8) ([@B48]) and Usp (Hcp domain containing protein of *E. coli*; UniProt: Q1RG83), respectively. Blue, green, and red indicate domains conserved in VgrG, TagD, and Hcp proteins, respectively. The VgrG-5 CTD is indicated in orange and accessory (effector) domains are highlighted in black. **(D)** Summary of T6SS-5 regulators discussed in the text that affect expression of T6SS-5 and other genes involved in host-pathogen interaction \[modified from ([@B22])\]. **(E)** Epifluorescence microscopy of *B. thailandensis* expressing a chromosomal *clpV-5-sfgfp* fusion during infection of Hela cells. ClpV-5-sfGFP shows foci formation at the bacterial cell pole and a diffuse localization in the cytoplasm. Actin was stained with Texas Red-Phalloidin. White arrows indicate the occurrence of actin tail formation and T6SS-5 expression and assembly in the same bacterial cell.](fmicb-09-03339-g001){#F1}

Components of the T6SS-5 Apparatus
==================================

The T6SS is a complex contractile injection system (CIS) exhibiting close structural and functional resemblance with other CIS such as myophage tails and R type pyocins ([@B98]; [@B52]; [@B36]). The T6S apparatus is composed of 14 core components termed Tss (type VI secretion system) and PAAR, and variably present Tag (type VI secretion system associated) proteins serving regulatory, structural or effector functions ([@B76]; [@B44]; [@B3]; [@B78]; [@B24]). Tss proteins assemble into three T6SS subcomplexes: a tubular system located in the cytoplasm consisting of the contractile sheath proteins TssB and TssC surrounding an inner tube formed by the Hcp (TssD) protein sharpened at one end by the TssI (VgrG) and PAARproteins, an envelope spanning membrane complex (TssM, TssL, and TssJ) and a base plate (TssE, TssF, TssG, and TssK) anchoring tube and sheath to the membrane complex ([@B19]; [@B110]; [@B62]). TssA was shown to initiate and coordinate sheath and tube polymerization during T6SS biogenesis ([@B111], [@B112]; [@B28]). The force-generating contraction of TssB and TssC acts as a molecular spring that pushes the inner Hcp tube tipped with the VgrG and PAAR spike proteins across the cell envelope into the target cell ([@B4]; [@B5]). Following translocation, the contracted sheath proteins are recycled by the ATPase ClpV (TssH) ([@B10]; [@B63]; [@B49]; [@B50]).

The vast majority of characterized T6SSs are employed by bacteria to inject toxic effector proteins into other prokaryotes ([@B69]; [@B25]; [@B42]; [@B72]). In addition, T6SSs specialized for effector protein delivery into eukaryotic cells including fungi and for the acquisition of metal ions have been described ([@B99]; [@B79]; [@B95]). This functional diversity extends to the mechanisms facilitating effector loading onto the T6SS. For instance, VgrG and PAAR (TagD) proteins can contain domains with effector function or act as carriers by binding to effector proteins while the Hcp tube can serve to translocate small (\<25 kDa) effector proteins ([@B65]; [@B80]; [@B30]; [@B96]; [@B9]; [@B58]; [@B66]).

In addition to the canonical T6SS^i^ subtype described above, which is predominantly found in Proteobacteria, other pathways (T6SS^ii-iv^) have been identified that differ in composition and taxonomic distribution ([@B11]; [@B13]; [@B70]; [@B31]; [@B7]). The *Burkholderia* T6SSs belong to the T6SS^i^ pathway. Two different nomenclatures exist for naming the T6SS gene clusters and components: cluster 1--6 T6SS ([@B73]) and T6SS-1--T6SS-6 ([@B76]). We adopted the nomenclature T6SS-1--T6SS-6 by Shalom et al., which is also universally used to name individual T6SS proteins. The T6SS-5 \[cluster 1 T6SS according to the nomenclature by [@B73]\] consists of the 13 Tss core components that are encoded by the same gene cluster (Table [1](#T1){ref-type="table"} and Figure [1B](#F1){ref-type="fig"}). Furthermore, four *tag* genes, *tagA/B-5*, *tagB-5*, *tagC-5* and *tagD-5*, are present in the T6SS-5 gene cluster whose role in T6SS-5 function is currently unknown. Primary sequence analysis indicates that TagA/B-5 and TagB-5 belong to the family of pentapeptide repeat proteins (PRP) ([@B76]). Examples of characterized PRPs are the cytoplasmic quinolone resistance protein Qnr in *E. coli* and PipB2, a kinesin-recruiting T3SS effector protein in *S*. *enterica* sv. Typhimurium ([@B94]; [@B41]). TagA/B-5 is essential for MNGC formation, full virulence in mice and Hcp-5 secretion indicating a critical role in T6SS-5 activity but not as an effector protein ([@B43]). TagD-5 is a PAAR-like protein comprising 130 amino acids that appears to lack effector domains and TagC-5 is a hypothetical protein of unknown function (DUF3540) (Figure [1C](#F1){ref-type="fig"}). Lastly, two regulatory genes are located within the T6SS-5 cluster encoding the two component regulator VirAG, which is required for transcriptional activation of T6SS-5 genes during infection ([@B22]).

###### 

Components of the T6SS-5 gene cluster in *B. pseudomallei* and *B. thailandensis*.

  Gene ID Bp^a^   Gene ID Bt^b^   Tss/Tag nomenclature   Alternative name   T6SS^i^ description/subcomplex
  --------------- --------------- ---------------------- ------------------ ---------------------------------------------------
  BPSS1493        BTH_II0873      *tssA-5*                                  Sheath/tube assembly coordination^c^
  BPSS1494        BTH_II0872      *virG*                                    Two component regulator VirAG; response regulator
  BPSS1495        BTH_II0871      *virA*                                    Two component regulator VirAG; sensor kinase
  BPSS1496        BTH_II0870      *tssB-5*                                  Contractile sheath
  BPSS1497        BTH_II0869      *tssC-5*                                  Contractile sheath
  BPSS1498        BTH_II0868      *tssD-5*               *hcp-5*            Tail tube/needle
  BPSS1499        BTH_II0867      *tssE-5*                                  Base plate
  BPSS1500        BTH_II0866      *tssF-5*                                  Base plate
  BPSS1501        BTH_II0865      *tssG-5*                                  Base plate
  BPSS1502        BTH_II0864      *tssH-5*               *clpV-5*           Sheath recycling AAA^+^ ATPase
  BPSS1503        BTH_II0863      *tssI-5*               *vgrG-5*           Spike protein
  BPSS1504        BTH_II0862      *tagA/B-5*                                Pentapeptide repeat protein
  BPSS1505        BTH_II0861      *tagB-5*                                  Pentapeptide repeat protein
  BPSS1506        BTH_II0860      *tagC-5*                                  Hypothetical
  BPSS1507        BTH_II0859      *tagD-5*                                  PAAR like protein/spike tip
  BPSS1508        BTH_II0858      *tssJ-5*                                  Membrane complex
  BPSS1509        BTH_II0857      *tssK-5*                                  Base plate
  BPSS1510        BTH_II0856      *tssL-5*                                  Membrane complex
  BPSS1511        BTH_II0855      *tssM-5*                                  Membrane complex
                                                                            

a

B. pseudomallei isolate K96243;

b

B. thailandensis isolate E264;

c

Dix et al. (2018)

.

Regulation of T6SS-5 Gene Expression
====================================

The first evidence of the induction of T6SS-5 gene expression by a host cell derived signal has been provided by an *in vivo* expression technology (IVET) study ([@B76]). The subsequent finding that the capability of vacuolar escape into the cytoplasm is a prerequisite for the activation of T6SS-5 genes suggested a cytoplasmic localization of the signal ([@B108]). Indeed, glutathione (GSH) and other low molecular weight (LMW) thiols such as cysteine have been identified to induce T6SS-5 gene expression ([@B108]). GSH is an antioxidant present at millimolar concentrations in the host cell cytoplasm. It contains one thiol group that acts as a reducing agent. Exposure of *B. pseudomallei* outside of host cells to reduced but not oxidized glutathione stimulated *hcp-5* expression by approximately 1000 fold ([@B108]). However, it is important to note that so far LMW thiols have been shown to induce transcription of T6SS-5 genes but not secretory activity of the T6SS-5. At present, the signal(s) necessary to elicit T6SS-5 contraction and secretion are not known.

Low molecular weight thiols are sensed by the sensor histidine kinase VirA of the two component system VirAG, which forms a dimer that is reduced by thiols to the active monomeric form ([@B108]). During infection of host cells VirAG positively regulates expression of *bimA* and T6SS-5 genes ([@B22]). *In trans* overexpression of *virAG* in *B. pseudomallei* and *B. thailandensis* activates the T6SS-5 and leads to Hcp-5 secretion in culture media ([@B73]; [@B17]; [@B74]; [@B92]). Furthermore, the transcription of T6SS-5 and T3SS-3 genes is co-regulated by BsaN encoded in the T3SS-3 gene cluster (Figure [1D](#F1){ref-type="fig"}). BsaN activates T3SS-3 effector and translocon genes, *virAG* and the regulatory gene *bprC*. BprC in turn induces expression of *tssB-5* and *tssC-5* ([@B22], [@B21]). Expression of T6SS-5 genes was shown to be co-regulated with that of T6SS-4 and secondary metabolite genes as well as a gene located next to the T6SS-5 gene cluster encoding a deubiquitinase that is secreted by the type II secretion system ([@B77]; [@B16]; [@B29]). Lastly, transcription of T6SS-5 genes is inhibited in the presence of iron and zinc ([@B15]).

Proteins Secreted by the T6SS-5
===============================

Taking advantage of the fact that *virAG* overexpression induces secretion of T6SS-5 in bacteria grown in culture medium, comparative mass spectrometric analysis of culture supernatants was performed to identify T6SS-5 effector proteins in *B. thailandensis*. Two proteins have been identified that were absent or of significantly lower abundance in the supernatant of a Δ*tssK-5* mutant relative to the wildtype: Hcp-5, the inner tube forming protein of T6SSs and VgrG-5, the needle spike protein ([@B74]). Hcp-5 does not appear to carry effector domains (Figure [1C](#F1){ref-type="fig"}). VgrG-5 contains an N- terminal and middle domain related to gp5 and gp27 bacteriophage spike forming proteins that are conserved in all T6SS^i^ VgrG proteins ([@B51]). However, VgrG-5 possesses an additional domain, located at the C-terminus (VgrG-5 CTD), that is unique to the *Burkholderia* genus (Figure [1C](#F1){ref-type="fig"}; [@B17]; [@B74]; [@B92]). Deletion of the VgrG-5 CTD abrogated cell-cell fusions and virulence in mice but did not affect secretion of Hcp-5 ([@B17]; [@B74]; [@B92]). This result suggests that VgrG-5 is a specialized VgrG protein and that its CTD has essential effector function ([@B65]; [@B30]; [@B74]). At present, VgrG-5 is the only T6SS-5 secreted protein identified with putative effector activity. Many other VgrG proteins containing additional domains at the C-terminus that display enzymatic activity, such as cross-linking of monomeric actin, have been described ([@B65]; [@B57]; [@B89]; [@B14]). However, the VgrG-5 CTD lacks significant sequence similarity to proteins of known function and further studies will be required to determine whether the protein exhibits membrane fusion activity. Furthermore, it cannot be excluded that the protein acts as a carrier for as yet unidentified T6SS-5 effectors.

Role of the T6SS-5 in the Intracellular Life Cycle and in Virulence *In Vivo*
=============================================================================

Several studies established a principal role of the *B. pseudomallei* and *B. thailandensis* T6SS-5 in inducing MNGC formation ([@B64]; [@B17]; [@B34]; [@B74]; [@B92]). The function of host cell fusion in the pathogenesis of melioidosis, however, has yet to be determined. *In vitro*, *B. pseudomallei* and *B. thailandensis* are capable of stimulating MNGC formation in a range of primary and immortalized cells ([@B47]; [@B100]; [@B103]). Obvious potential benefits of this host cell manipulation are access to nutrients provided by uninfected host cells, and localized spread and replication without exposure to extracellular immune defense mechanisms.

Like T6SS-5 mutants, T3SS-3 mutants of *B. pseudomallei* display a host cell fusion defect ([@B90]; [@B60]; [@B39]). Since T3SS-3 mutants are impaired in vacuolar escape into the cytoplasm -- a requirement for the induction of T6SS-5 gene expression-- the role of T3SS-3 in MNGC formation could be indirect. To clarify the function of the T3SS-3 in MNGC formation, French et al. utilized a photothermal nanoblade to place a *B. thailandensis* T3SS-3 mutant from the extracellular milieu directly into the cytoplasm of the host cell thereby bypassing endocytic vesicle enclosure and escape ([@B34]). The finding that the mutant was able to induce host cell fusion following nanoblade delivery conclusively demonstrated that the T3SS-3 is not involved in this process.

In addition to T6SS-5 genes and *bimA* being co-regulated by VirAG, it has been shown that the deletion of structural components of the T6SS-5 reduced actin tail formation in *B. pseudomallei* and *B. mallei* ([@B18];[@B22]). The underlying basis of this effect is currently unclear. Interestingly, however, the ability of the bacteria to move in the host cell cytoplasm is a prerequisite for the stimulation of cell-cell fusion. Disruption of intracellular motility of *B. pseudomallei* and *B. thailandensis* almost entirely abolished MNGC formation ([@B34]). This observation suggests a site-specific induction of T6SS-5 secretion inside the host cell that leads to cell-cell fusion. Alternatively, intracellular motility was proposed to be required to bring the plasma membrane of neighboring host cells into close proximity before they are punctured by the T6SS-5 to create a hemifusion zone leading to cell-cell fusion ([@B92]). In support of these notions, fluorescence microscopy of *B. thailandensis* expressing *clpV-5-sfgfp* during infection showed actin tail formation and T6SS-5 expression in the same bacterial cell (Figure [1E](#F1){ref-type="fig"}; [@B74]).

The deletion of essential T6SS-5 genes drastically decreased virulence of *B. pseudomallei* and *B. thailandensis* in mammalian models of acute infection ([@B64]; [@B75], [@B74]; [@B17]; [@B43]). Intranasal inoculation of mice with *B. pseudomallei* wildtype and *tssK-5* and *tagA/B-5* mutants showed a significant attenuation of virulence upon T6SS-5 disruption ([@B64]; [@B43]). CFU measurements of lung, liver, and spleen revealed that T6SS-5 mutants were able to disseminate to distant sites although the bacterial load in the organs was significantly lower compared with wildtype challenged mice. Likewise, the LD~50~ of a *B. pseudomallei hcp*-5 mutant in hamsters after intraperitoneal challenge was 1000 fold higher than that of the wildtype ([@B17]). Furthermore, after high dose pulmonary infection with *B. thailandensis* wildtype all mice succumbed whereas a *tssK*-5 mutant failed to cause lethal infections and to proliferate in the lung, liver and spleen ([@B75]). However, the *tssK*-5 mutant caused rapidly fatal infections in mice lacking the innate immune adapter molecule MyD88, which contributes to neutrophil recruitment and activation in mice infected with *B. pseudomallei* ([@B105]). The finding that the *B. thailandensis tssK-5* mutant is highly virulent in MyD88^-/-^ mice indicates that the T6SS-5 is required to overcome MyD88-dependent immune responses to establish an infection ([@B75]). *In vitro*, T6SS-5 mutants are able to multiply in the host cell cytoplasm ([@B76]). Thus, the mere ability to replicate in the intracellular compartment appears to be a necessary but not sufficient trait of *B. pseudomallei* to cause disease. Lastly, virulence of T6SS-5 mutants of *B. pseudomallei*, *B. thailandensis* and *B. mallei* was attenuated in a cockroach model of infection ([@B33]).

Conclusion and Future Perspective
=================================

Many fundamental questions remain unanswered since the discovery of the vital role of the T6SS-5 in *B. pseudomallei*-host cell interaction over 10 years ago. Critically, deciphering the mode of action of the T6SS-5 poses a challenge for the field as it still remains elusive although an essential candidate effector has been identified. In particular, important unsolved questions are: What is the exact subcellular localization of translocated VgrG-5 and does it function as membrane fusion protein? Is the VgrG-5 CTD sufficient for mediating cell-cell fusion or are other (T6SS-5) proteins involved in the process? Does the T6SS-5 employ host cellular factors to exert its function? In addition, investigating the molecular and cellular details of the MyD88-dependent immune response that facilitates control of T6SS-5 mutant bacteria will improve our understanding of T6SS-5 function. To answer these questions *B. thailandensis* will be an ideal model organism as work with this bacterium is less laborious and less restricted with respect to for example high throughput and *in vivo* imaging techniques compared with *B. pseudomallei*. Advancing knowledge on the molecular basis of the T6SS-5 -- a key virulence determinant of *B. pseudomallei* -- will benefit the development of strategies to disable the capacity of the pathogen to survive and proliferate in humans.

Author Contributions
====================

JL and TW wrote the manuscript. SS conceived and wrote the manuscript.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** JL was funded by the German Research Foundation (SFB766/Project B16). Work by SS was supported by the German Research Foundation (DFG SCHW 1517/1-1 and SCHW 1517/3-1) and the German Excellence Initiative.

We apologize to those whose work was not mentioned due to space limitations.

[^1]: Edited by: Alain Pierre Gobert, Vanderbilt University Medical Center, United States

[^2]: Reviewed by: Mark Stephen Thomas, University of Sheffield, United Kingdom; Jo Stevens, University of Edinburgh, United Kingdom

[^3]: This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
